FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Clinical trials for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to speed up FSHD drug trials
Knowledge-focused OngoingThis study is not testing a new treatment. Instead, it aims to make future drug trials for facioscapulohumeral muscular dystrophy (FSHD) faster and more effective. Researchers are testing new ways to measure muscle function and refining who should be included in trials. 324 adult…
Matched conditions: FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New study aims to measure muscle decline in Wheelchair-Using FSHD patients
Knowledge-focused OngoingThis study focuses on improving how we measure disease progression in people with advanced Facioscapulohumeral Muscular Dystrophy (FSHD) who use wheelchairs. Researchers will test various physical tests and assessments over two years in 30 participants. The goal is to find reliab…
Matched conditions: FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC